Revolution Medicines, Inc. (RVMD) Profit Margin
Revolution Medicines, Inc. (RVMD) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2020-12-31 | -251.63% |
| 2021-12-31 | -636.58% |
| 2022-12-31 | -702.95% |
| 2023-12-31 | -3768.28% |
| 2024-12-31 | -106968.45% |
| 2025-12-31 | N/A |
How RVMD compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| VTGN | Vistagen Therapeutics Inc. | -5491.33% |
| PLSE | Pulse Biosciences Inc | -20794.57% |
| BNTC | Benitec Biopharma Inc. | -26082.67% |
| INMB | INmune Bio Inc. | -91800.00% |
| INO | Inovio Pharmaceuticals Inc. | -130000.00% |
These are five companies in the same sector as RVMD with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Revolution Medicines, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("RVMD", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RVMD | $203.71 | +0.85% | 0.78M |
| 3 | ||||
| 4 | ||||
| 5 |